ELAPRASE
NDC 54092-700 · Takeda Pharmaceuticals America, Inc.
Generic nameidursulfase
Dosage formSOLUTION, CONCENTRATE
RouteINTRAVENOUS
Active ingredient(s)IDURSULFASE
Strength6 mg/3mL
Pharmacologic classHydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC], alpha-Glucosidases [CS]
Marketing categoryBLA
Packages
54092-700-01 — 1 VIAL, GLASS in 1 BOX (54092-700-01) / 3 mL in 1 VIAL, GLASS
Billed under HCPCS
J1743 — Injection, idursulfase, 1 mg Medicare Part B payment limit (ASP + 6%): $570.04